RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status

RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status

10.1007/s12253-011-9485-5

Saved in:
Bibliographic Details
Main Authors: Omar, M.F.M., Ito, K., Nga, M.E., Soo, R., Peh, B.K., Ismail, T.M., Thakkar, B., Soong, R., Ito, Y., Salto-Tellez, M.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2014
Subjects:
EGFR
KRAS
Lung adenocarcinoma
P53
Promoter hypermethylation
RUNX3
Online Access:http://scholarbank.nus.edu.sg/handle/10635/116580
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-116580
record_format dspace
spelling sg-nus-scholar.10635-1165802023-10-30T09:19:14Z RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status Omar, M.F.M. Ito, K. Nga, M.E. Soo, R. Peh, B.K. Ismail, T.M. Thakkar, B. Soong, R. Ito, Y. Salto-Tellez, M. CANCER SCIENCE INSTITUTE OF SINGAPORE EGFR KRAS Lung adenocarcinoma P53 Promoter hypermethylation RUNX3 10.1007/s12253-011-9485-5 Pathology and Oncology Research 18 4 783-792 POREF 2014-12-12T07:51:37Z 2014-12-12T07:51:37Z 2012-10 Article Omar, M.F.M., Ito, K., Nga, M.E., Soo, R., Peh, B.K., Ismail, T.M., Thakkar, B., Soong, R., Ito, Y., Salto-Tellez, M. (2012-10). RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status. Pathology and Oncology Research 18 (4) : 783-792. ScholarBank@NUS Repository. https://doi.org/10.1007/s12253-011-9485-5 12194956 http://scholarbank.nus.edu.sg/handle/10635/116580 000309104700005 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic EGFR
KRAS
Lung adenocarcinoma
P53
Promoter hypermethylation
RUNX3
spellingShingle EGFR
KRAS
Lung adenocarcinoma
P53
Promoter hypermethylation
RUNX3
Omar, M.F.M.
Ito, K.
Nga, M.E.
Soo, R.
Peh, B.K.
Ismail, T.M.
Thakkar, B.
Soong, R.
Ito, Y.
Salto-Tellez, M.
RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
description 10.1007/s12253-011-9485-5
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Omar, M.F.M.
Ito, K.
Nga, M.E.
Soo, R.
Peh, B.K.
Ismail, T.M.
Thakkar, B.
Soong, R.
Ito, Y.
Salto-Tellez, M.
format Article
author Omar, M.F.M.
Ito, K.
Nga, M.E.
Soo, R.
Peh, B.K.
Ismail, T.M.
Thakkar, B.
Soong, R.
Ito, Y.
Salto-Tellez, M.
author_sort Omar, M.F.M.
title RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
title_short RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
title_full RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
title_fullStr RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
title_full_unstemmed RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status
title_sort runx3 downregulation in human lung adenocarcinoma is independent of p53, egfr or kras status
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/116580
_version_ 1781789537807106048

Similar Items